Company intelligence / Profile preview

Taryag Medical

Ownership: Private
Development stage: Commercial

Overview

Taryag Medical has developed BYCROSS®, a minimally invasive rotational atherectomy catheter with an expandable tip and simultaneous aspiration system for the treatment of peripheral arterial occlusions. The product enables percutaneous revascularization even in cases where guidewire passage through the occlusion cannot be achieved, potentially avoiding bypass surgery or amputation. Clinical results are not detailed publicly but the product's commercial status suggests successful validation and adoption.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically rotational atherectomy catheter)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Taryag Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taryag Medical.

Explore the full profile